About Molecular Matrix
Molecular Matrix is a Healthcare company based in Davis (United States) founded in 2011. Advanced tools for stem cell cultivation and study are provided. Molecular Matrix has raised $985.42 thousand across 3 funding rounds. Molecular Matrix offers products and services including Osteo-P Bone Graft Substitute and Diagnostics Services. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified. Its legal entity is Molecular Matrix, Inc. Its competitors include Avidity Biosciences, Sutro Biopharma and Antheia; 3 of its 3 listed competitors have raised funding.
Company details
Molecular Matrix was founded in 2011 in Davis, United States, within the biotechnology sector. Research tools for three-dimensional stem cell cultivation and analysis are developed and supplied. The GroCell-3D portfolio includes scaffolds in multiple formats, a dedicated cell culture system, and a scaffold-dissolving solution for cell recovery. Services encompassing stem cell isolation, culture maintenance, and analytical evaluation are also offered to support scientific operations.
- Headquarters Davis, United States
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Website molecularmatrix.com
- Social LinkedIn X Facebook Instagram
- Legal Name Molecular Matrix, Inc.
- Total Equity Funding$985.42K (USD)
in 3 rounds
- Latest Funding Round$855.42K (USD), Seed
Jan 2018
Products & Services of Molecular Matrix
Molecular Matrix offers a comprehensive portfolio of products and services, including Osteo-P Bone Graft Substitute and Diagnostics Services.
Provides substitute for bone regeneration in orthopedic procedures.
Offers testing support, though no longer active as per records.
Funding Insights of Molecular Matrix
Molecular Matrix has successfully raised a total of $985.42K across 3 strategic funding rounds. The most recent funding activity was a Seed round of $855.42 thousand completed in January 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $985,416
- Total Rounds 3
- Last Round Seed — $855,416
- First Round $50,000
(Nov 2013)
All 3 funding rounds of Molecular Matrix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2018 | $855,416 | Seed | – | – | – |
| Jan 2015 | $80,000 | Seed | – | – | – |
| Nov 2013 | $50,000 | Seed | – | – | – |
People of Molecular Matrix
9 people are tracked at Molecular Matrix (7 in leadership, 1 in board & advisors, 1 in team).
| Name | Role | Group |
|---|---|---|
Christopher Wink | Chief Financial Officer | Leadership |
Charles Lee | Founder, CEO & Chairman | Leadership |
Michele Martinez | Chief Operating Officer | Leadership |
Justin Judd | Vice President Research And Development | Leadership |
Jon Eynon | Director Of Business Development | Leadership |
Plamena Koleva | Director of Preclinical and Clinical Development | Leadership |
Naoki Hirasawa | Director Of Operations | Leadership |
Jim Keefer | Board Member | Board & advisors |
Bryan Davis | Regional Sales Manager, East | Team |
Complete people profiles for Molecular Matrix
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Molecular Matrix
3 dated milestones of Molecular Matrix across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Molecular Matrix is founded.
- Funding First funding round of $50K.
- Funding Latest funding round, Seed, of $855K.
Competitors of Molecular Matrix
Molecular Matrix has 3 listed competitors in our database, 3 of them funded. They include Avidity Biosciences, Sutro Biopharma and Antheia.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. |
Detailed competitors of Molecular Matrix
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Molecular Matrix
The website of Molecular Matrix (molecularmatrix.com) receives about 1.5K visits a month and ranks #11,523,751 among all websites worldwide, #8,126 in Biotechnology and Pharmaceuticals.
- Monthly visits1.5K
▲ 28.9% vs previous month
- Global rank#11,523,751
among all websites
- Category rank#8,126
Health · Biotechnology and Pharmaceuticals
- Bounce rate38%
- Pages per visit2.1
- Average visit57 sec
- DevicesDesktop 33% · Mobile 67%
Websites whose visitors overlap most with Molecular Matrix. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| orcabio.com | 100% | 7.8K | #3,522,870 | View details | |
| gsk.com | 46% | 1.3M | #56,834 | View details | |
cichlidresearch.com | cichlidresearch.com | 32% | #14,672,194 | – | |
handbiolab.com | handbiolab.com | 32% | #4,240,186 | – | |
| nivagen.com | 31% | 8.5K | #2,347,838 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 12 similar websites and full traffic analytics for Molecular Matrix
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 12 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Molecular Matrix (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Molecular Matrix
Molecular Matrix was founded in 2011 and raised its 1st funding round 2 years after it was founded.
Molecular Matrix is headquartered in Davis, United States. It is registered at Davis, California, United States.
Molecular Matrix is a funded company, having raised a total of $985.42K across 3 funding rounds to date. The company's 1st funding round was a Seed of $50K, raised on Nov 2013.
Molecular Matrix was founded in 2011 in Davis, United States, within the biotechnology sector. Research tools for three-dimensional stem cell cultivation and analysis are developed and supplied. The GroCell-3D portfolio includes scaffolds in multiple formats, a dedicated cell culture system, and a scaffold-dissolving solution for cell recovery. Services encompassing stem cell isolation, culture maintenance, and analytical evaluation are also offered to support scientific operations.
Molecular Matrix's top competitors include Sutro Biopharma, Avidity Biosciences and Antheia.
Molecular Matrix offers Osteo-P Bone Graft Substitute and Diagnostics Services.
Molecular Matrix operates through Molecular Matrix, Inc..